Mallinckrodt Reports on FDA Joint Advisory Committee Meeting for Stannsoporfin for the Treatment of Newborns at Risk of Developing Severe Jaundice

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 6/23/2026

1. SPCX
2. ABBV
3. META
4. SPY
5. FDX
6. IBM
7. MU
8. ACN
9. USO
10. NVDA

Go back to Mallinckrodt Reports on FDA Joint Advisory Committee Meeting for Stannsoporfin for the Treatment of Newborns at Risk of Developing Severe Jaundice

Mallinckrodt (MNK) Seen as Target of Negative Upcoming 60 Minutes Episode

May 4, 2018 10:06 AM EDT

Mallinckrodt (NYSE: MNK) is seen as the target of an upcoming 60 Minutes episode.

"THE ROCKFORD FILE A look at the fight that Rockford, Ill., took up against the high cost of prescription drugs explains why they cost more in the U.S.... More